Impact of Black Seed Oil on Hemodialysis Patients - Trial NCT05822661
Access comprehensive clinical trial information for NCT05822661 through Pure Global AI's free database. This Phase 2 trial is sponsored by Ain Shams University and is currently Not yet recruiting. The study focuses on End Stage Renal Disease. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ain Shams University
Timeline & Enrollment
Phase 2
Feb 22, 2023
Apr 23, 2023
Primary Outcome
serum Endothelin-1 (ET-1) level
Summary
The aim of the study is to evaluate the effect of black seed oil on endothelial dysfunction,
 oxidative stress and quality of life in hemodialysis patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05822661
Non-Device Trial